Roche Plans $50 Billion Investment to Expand US Pharmaceuticals and Diagnostics
The investment will be done over five years and will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple US states.
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.
Rentschler Biopharma Withdraws from Cell and Gene Field, Plans to Close UK Site
Prior to this announcement, Rentschler announced in September 2024 it would be launching an expanded service offering at its advanced therapies site in Stevenage, UK, which is now being shut down.
Vaccines and Virus Purification through the Ages
Learn Morewww.bio-rad.com/fluvaccine
Cytiva and Cellular Origins Team Up on Delivering Automated CGT Manufacturing
The collaboration will combine Cytiva’s CGT manufacturing technologies with Cellular Origins' robotic manufacturing platform.
PackGene Forms Global Alliance with Non-Profit GC4K and Weill Cornell Medicine for Gene Therapy Treatment for Rare Neurological Disease
Under a global alliance with the Australian non-profit GC4K and Weill Cornell Medicine, PackGene aims to deliver a custom-tailored gene therapy solution for hereditary spastic paraplegia type 56, an exceptionally rare neurological disease.
